Pulmonary Embolism (PE): Causes, Symptoms, Diagnosis, and Treatment

Pulmonary embolism (PE) is one of the most dangerous cardiovascular conditions, often leading to severe complications and even death if not treated promptly.

PE occurs when a blood clot or other substance blocks a pulmonary artery in the lungs, causing a disruption in the blood flow and oxygen levels in the body.

This condition can develop suddenly and may progress quickly, making it crucial for people to understand the risk factors, symptoms, causes, diagnosis, treatment options, and preventive measures.

In this comprehensive article, we will explore pulmonary embolism in great detail, including what causes PE, the various PE symptoms associated with it, how it can be diagnosed, treatment options, and how early intervention can help save lives.

We’ll also dive into how to prevent PE, common misconceptions, and the importance of awareness. Let’s begin by understanding the basics of pulmonary embolism.

Table of Contents

What is Pulmonary Embolism (PE)?

A pulmonary embolism (PE) is a blockage in one of the pulmonary arteries in the lungs, typically caused by a blood clot that travels from the deep veins of the legs or other parts of the body (known as deep vein thrombosis (DVT)).

When a clot lodges in the pulmonary arteries, it disrupts normal blood circulation and impairs the lungs’ ability to exchange oxygen with the blood.

The lungs receive blood from the heart through the pulmonary arteries, and once blood flows through the lungs, it is oxygenated before being pumped back to the rest of the body.

However, if a clot blocks this crucial blood flow, the oxygen supply to the organs is compromised.

The severity of pulmonary embolism depends on the size of the clot and where it is located in the pulmonary arteries:

Large clots can block major arteries, leading to severe respiratory failure.
Smaller clots might partially obstruct blood flow, causing symptoms like shortness of breath, but they can still be dangerous over time if left untreated.

In severe cases, the blockage can lead to shock (a condition where the body’s vital organs do not receive enough blood), cardiac arrest, or even death.

Types of Pulmonary Embolism (PE)

1. Massive PE

A massive PE is a large clot that blocks a major pulmonary artery or multiple pulmonary arteries, which can cause severe respiratory distress and cardiovascular collapse.

Massive PEs are a medical emergency and are often associated with sudden death if not treated immediately.

These large clots obstruct the heart’s ability to pump oxygenated blood to the rest of the body, leading to life-threatening complications.

2. Massive PE

A submassive PE involves a clot that is moderate in size and obstructs some but not all of the pulmonary arteries.

These clots are not as immediately life-threatening as a massive PE, but they can still cause serious damage to the lungs and heart. Submassive PE requires urgent treatment to prevent further complications.

3. Minor PE

A minor PE refers to small clots that travel to the lungs but cause less severe symptoms.

In some cases, these clots may be asymptomatic, meaning they do not present noticeable symptoms at first. However, even small clots can still be dangerous and may lead to long-term complications if recurrent or left untreated.

Prevalence of Pulmonary Embolism (PE)

Pulmonary embolism is a significant global health concern, affecting millions of people every year.

According to the CDC, each year in the U.S. alone, 300,000 to 600,000 individuals are affected by deep vein thrombosis (DVT) and pulmonary embolism.

It is estimated that 100,000 to 200,000 Americans die annually from PE-related complications.

Globally, the incidence of PE varies based on regions and healthcare accessibility.

It is more common in developed countries, where there is better access to diagnostic tools, yet PE-related deaths remain a significant concern in developing regions due to the lack of early detection and appropriate medical interventions.

Causes of Pulmonary Embolism (PE)

1. Blood Clots (Deep Vein Thrombosis – DVT)

The most common cause of pulmonary embolism is deep vein thrombosis (DVT). DVT occurs when a blood clot forms in the deep veins of the legs, pelvis, or other areas of the body.

If the clot breaks free, it can travel through the bloodstream to the lungs, where it can block a pulmonary artery and disrupt normal blood flow.

Several conditions contribute to the formation of DVT, which can lead to PE:

Prolonged immobility: When blood flow slows due to lack of movement, it can lead to clot formation. People who spend long periods in bed after surgery or during illness are particularly at risk.
Heart disease: Certain heart conditions can increase the risk of DVT and PE. For example, individuals with atrial fibrillation or heart failure are more likely to experience clot formation.
Cancer: Some cancers and cancer treatments, such as chemotherapy, increase the risk of developing blood clots. The body’s response to cancerous cells can also contribute to a hypercoagulable state.
Recent surgery or injury: Surgeries, especially those involving the lower extremities (such as joint or hip surgeries), increase the risk of blood clot formation. Injuries to the legs can also contribute to clot formation, especially if blood flow is impeded during recovery.

2. Fat Embolism

A fat embolism occurs when fat from broken bones, particularly long bones like the femur, enters the bloodstream. This fat can travel to the lungs, causing a blockage in the pulmonary arteries.

Fat embolisms are most commonly seen in trauma patients and individuals with fractures, especially those who experience multiple fractures or severe trauma.

3. Air Embolism

An air embolism occurs when air bubbles enter the bloodstream, which can happen during surgical procedures or trauma.

This can happen, for example, when air is introduced into the bloodstream during medical procedures like intravenous catheter insertion or lung surgery. Air embolisms can be fatal if not detected and treated quickly.

4. Amniotic Fluid Embolism

An amniotic fluid embolism is a rare but extremely serious condition that occurs during childbirth.

It happens when amniotic fluid (the fluid surrounding the baby in the uterus) or fetal cells enter the mother’s bloodstream, causing a pulmonary embolism. This type of embolism is rare, but it is often life-threatening for the mother.

Risk Factors of Pulmonary Embolism (PE)

1. Age: Older Adults Are More at Risk

The risk of PE increases with age, particularly after the age of 60.

This is because blood flow naturally slows with age, and older adults often experience other health issues, such as heart disease or cancer, which further increase the likelihood of clot formation.

2. Immobility: Long Periods of Bed Rest, Sitting, or Paralysis

When the body is inactive, blood flow slows down, especially in the legs, increasing the risk of deep vein thrombosis (DVT).

For individuals who are bedridden due to illness, surgery, or injury, or those who are paralyzed, the risk of clot formation and subsequent PE rises significantly.

Additionally, long periods of sitting, such as during long flights or car rides, can also cause blood to pool in the legs, leading to clot formation.

3. Medical Conditions: Heart Disease, Cancer, or Respiratory Diseases

Several medical conditions increase the risk of pulmonary embolism:

Heart disease: The conditions, including atrial fibrillation or heart failure, disrupt normal blood flow, increasing the chance that a clot will form and travel to the lungs.
Cancer: Certain cancers, including pancreatic cancer, lung cancer, and cervical cancer, increase the risk of developing blood clots in lungs. Cancer and its treatments, such as chemotherapy, can make the blood more prone to clotting.
Respiratory diseases: Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) or emphysema, can also increase the risk of PE because they often lead to reduced mobility and increased strain on the heart, making blood clotting more likely.

4. Recent Surgery or Injury: Especially Joint or Hip Surgery

People who have undergone major surgery, especially joint replacement surgeries (such as hip or knee surgeries), have an elevated risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE).

The risk is highest immediately following surgery when patients are less mobile and blood flow is slow.

5. Hormonal Factors: Birth Control Pills or Hormone Replacement Therapy (HRT)

Hormonal treatments, such as birth control pills and hormone replacement therapy (HRT), can increase the formation risk of blood clot in lung.

Both birth control pills and HRT raise levels of estrogen, which can make the blood more likely to clot.

Women who smoke and use birth control pills are at an even higher risk.

6. Pregnancy and Childbirth: Increased Risk During the Third Trimester and After Delivery

During pregnancy, the body experiences increased clotting factors, and blood flow slows down in the legs due to the growing uterus.

This is especially true during the third trimester when the uterus presses on veins, making it harder for blood to return to the heart.

7. Obesity

Obesity significantly increases the risk of developing deep vein thrombosis and pulmonary embolism.

People who are overweight or obese often have slower blood circulation and more pressure on their veins, which leads to an increased likelihood of clot formation.

Obesity also contributes to other health conditions, such as heart disease and diabetes, that further increase the risk of PE.

8. Smoking and Lifestyle

Smoking damages the walls of blood vessels, increasing the likelihood of clot formation.

Smoking also contributes to chronic obstructive pulmonary disease (COPD), which further elevates the risk of developing PE.

In combination with other risk factors such as obesity or physical inactivity, smoking significantly worsens the chances of developing a pulmonary embolism.

Symptoms of Pulmonary Embolism (PE)

Pulmonary embolism symptoms can vary from mild to severe and may occur suddenly. In some cases, a pulmonary embolism can be asymptomatic, especially if the clot is small.

However, large emboli or multiple emboli can cause life-threatening symptoms. Common symptoms include:

1. Shortness of Breath

One of the most common symptoms of pulmonary embolism is sudden shortness of breath, which may occur without any prior chest pain.

This happens because the clot blocks blood flow to the lungs, reducing the lungs’ ability to exchange oxygen with the bloodstream.

2. Chest Pain

Sharp or stabbing chest pain is another hallmark symptom of PE, particularly when the pain worsens with deep breaths.

This is caused by the clot blocking blood flow to the lungs, which can lead to inflammation and irritation of the lung tissue.

3. Coughing

Coughing is common with PE, especially if the embolism leads to inflammation or pulmonary infarction (tissue death in the lungs).

Coughing up blood (hemoptysis) can also occur in severe cases, indicating that the clot has caused significant damage to lung tissue.

4. Rapid Heartbeat (Tachycardia)

Increased heart rate is common in individuals with pulmonary embolism.

The heart works harder to compensate for the reduced oxygen levels caused by the blockage in the lungs. Tachycardia is often accompanied by dizziness and lightheadedness.

5. Swelling in the Legs

Swelling, especially in one leg, is another key symptom of pulmonary embolism.

The swelling is caused by the clot that formed in the leg veins (DVT) and may be accompanied by redness, warmth, and pain. This is a sign that the clot has traveled to the lungs, causing a PE.

6. Lightheadedness or Fainting

If a PE causes severe oxygen deprivation or strain on the heart, individuals may experience lightheadedness, fainting, or feeling dizzy.

Diagnosis of Pulmonary Embolism (PE)

1. Clinical Assessment

The first step in diagnosing PE involves taking a detailed medical history and performing a physical examination.

The doctor will assess risk factors (e.g., recent surgery, prolonged immobility, family history) and symptoms to evaluate the likelihood of PE.

One of the most commonly used tools for risk assessment is the Wells score, which helps physicians determine the probability of a PE based on clinical findings.

2. D-Dimer Test

A D-dimer test measures the presence of fibrin degradation products in the blood. High levels of D-dimer can indicate that blood clots are present in the body.

However, this test is not definitive for PE, as elevated levels of D-dimer can also occur in other conditions such as infection or cancer.

3. CT Pulmonary Angiography (CTPA)

CT Pulmonary Angiography (CTPA) is the gold standard for diagnosing PE.

This imaging test uses contrast dye and a CT scan to visualize the pulmonary arteries and detect the presence of clots. CTPA is fast, accurate, and commonly used in emergency departments.

4. Ventilation-Perfusion (V/Q) Scan

The V/Q scan is an alternative to CTPA, especially for patients who cannot tolerate contrast dye.

This test involves inhaling a radioactive substance to evaluate lung function and blood flow. A mismatch between ventilation and perfusion can suggest the presence of a pulmonary embolism.

5. Ultrasound

If deep vein thrombosis (DVT) is suspected to be the source of the clot, ultrasound of the legs can be used to detect blood clots in the deep veins.

Treatment for Pulmonary Embolism (PE)

Treatment for pulmonary embolism focuses on stabilizing the patient, removing or dissolving the clot, and preventing future clots.

1. Anticoagulants (Blood Thinners)

The main treatment for PE is the use of anticoagulants, or blood thinners, to prevent further clotting.

Medications such as heparin, warfarin, and direct oral anticoagulants (DOACs) help prevent the formation of new clots and give the body time to break down the existing clot.

2. Thrombolytics (Clot-Busting Drugs)

For severe cases of PE, especially massive embolism that threatens life, thrombolytics (clot-busting drugs) may be administered.

These drugs work by dissolving the clot quickly and restoring normal blood flow. However, thrombolytics carry a higher risk of bleeding and are generally reserved for life-threatening cases.

3. Surgical Intervention

In some cases, particularly when the clot is large or resistant to other treatments, surgical removal of the clot (embolectomy) may be necessary. This procedure is typically performed in emergency situations.

4. Inferior Vena Cava (IVC) Filter

An IVC filter is a small device placed in the large vein (vena cava) that prevents blood clots from traveling to the lungs.

This treatment is often used in patients who cannot take anticoagulants or who are at high risk for recurrent embolisms.

Complications of Pulmonary Embolism (PE)

Chronic pulmonary hypertension: Repeated or untreated PE can cause long-term damage to the lungs and heart, leading to chronic high blood pressure in the lungs.
Recurrent PE: Without addressing the underlying causes, there’s an increased risk of further pulmonary emboli, which can worsen lung and heart function.
Right-sided heart failure: PE places extra strain on the right side of the heart, which can lead to heart failure as the heart struggles to pump blood through the lungs.
Death: Massive PE can result in sudden death, emphasizing the critical need for early detection and prompt treatment to save lives.

Prevention and Long-Term Management of Pulmonary Embolism (PE)

1. Anticoagulant Therapy (Blood Thinners)

Patients undergoing major surgery, those with deep vein thrombosis (DVT), or individuals with certain heart conditions may be prescribed anticoagulants to prevent PE.

Common blood thinners include:

Heparin: Often used in hospital settings.
Warfarin: A long-term blood thinner that requires monitoring.
Direct oral anticoagulants (DOACs): Such as rivaroxaban and apixaban, which are increasingly used due to their ease of use and fewer dietary restrictions.

2. Compression Stockings

Compression stockings apply gentle pressure to the legs, promoting blood flow and preventing blood from pooling, which can lead to clot formation.

They are especially important in patients undergoing joint replacement surgery or those who are immobile for extended periods.

3. Early Mobilization

Getting patients moving as soon as possible after surgery or during recovery from illness is a key preventive measure. Early mobilization encourages circulation and reduces the risk of clot formation.

For long-duration travelers (e.g., long flights), walking every couple of hours, stretching, or using compression socks can help keep blood circulating.

4. Lifestyle Changes

Certain lifestyle changes can significantly lower the risk of PE:

Weight management: Maintaining a healthy weight reduces the pressure on the veins in the legs and helps prevent DVT and PE.
Physical activity: Regular exercise improves circulation, which prevents blood from pooling in the legs and forming clots.
Smoking cessation: Smoking harms blood vessel health, making clot formation more likely, so quitting smoking can significantly lower the risk of PE.

5. Surgical and Mechanical Devices

For high-risk patients, particularly those who cannot take blood thinners due to contraindications (such as active bleeding), a filter may be inserted into the inferior vena cava (IVC).

The IVC filter acts as a catchment device to prevent blood clots from reaching the lungs and causing PE.

6. Regular Monitoring and Follow-Up

Patients who have had a PE should receive regular follow-up appointments to monitor their condition. This may include:

Blood tests to check the levels of anticoagulants and ensure proper dosing.
Imaging studies like ultrasound to detect any remaining or new clots in the legs (DVT).
CT scans to assess any long-term lung damage caused by the embolism.

Prognosis of Pulmonary Embolism (PE)

Survival Rates:

Early diagnosis and prompt intervention can significantly improve survival rates.

Massive PE, which involves a large clot that blocks a major pulmonary artery, has a mortality rate of approximately 30% within the first hour if untreated. However, thrombolytic therapy (clot-busting drugs) can improve survival rates. When thrombolytics are administered early, the survival rate can increase significantly, with studies showing 50-70% survival in patients with massive PE who receive timely treatment.
Submassive PE, where the clot is moderate in size, has a mortality rate of around 5-15%, depending on the underlying health of the patient and how quickly medical care is provided.
Minor PE, which involves smaller clots that may not cause severe symptoms, has a relatively low mortality rate, estimated at 1-3%. These cases often go undiagnosed until routine imaging, but with proper management, patients typically recover fully.

Long-Term Outlook:

With prompt treatment, many individuals recover fully, especially if the PE is caught early and treated effectively.

However, some may experience long-term complications, such as pulmonary hypertension, a condition where the blood pressure in the lungs remains elevated.

Additionally, recurring PE episodes can lead to chronic lung damage, affecting overall heart and lung function over time.

FAQs

1. What are the first signs of a pulmonary embolism?

The first signs of a pulmonary embolism often include sudden shortness of breath, sharp chest pain that worsens with deep breaths, and a rapid heartbeat.

Some patients may also cough up blood or experience dizziness.

2. Can pulmonary embolism be cured?

There is no “cure” for pulmonary embolism, but it can be effectively treated.

Blood thinners (anticoagulants), thrombolytics (clot-busting drugs), and surgical procedures like embolectomy can help dissolve or remove the clot and reduce complications.

3. What are pulmonary embolism causes?

Pulmonary embolism is caused by a blood clot in lungs, typically from the deep veins of the legs (deep vein thrombosis or DVT).

Other causes of PE include fat embolisms, air embolisms, and, rarely, amniotic fluid embolisms during childbirth.

4. What is the difference between a blood clot and pulmonary embolism?

A blood clot can form anywhere in the body, but when it travels to the lungs and blocks a pulmonary artery, it becomes a pulmonary embolism (PE).

PE can cause severe respiratory issues and can be life-threatening if not treated quickly.

5. Can you survive a pulmonary embolism?

Survival rates vary depending on the size and location of the clot and how quickly it is treated.

With prompt medical intervention, the survival rate for pulmonary embolism is good. However, untreated massive PE has a higher risk of death.

Conclusion

Pulmonary embolism (PE) is a serious condition that requires swift recognition and treatment.

The risk of developing PE increases in individuals who are sedentary, recently underwent surgery, or have underlying conditions like heart disease or cancer.

Early diagnosis and the use of medications, such as anticoagulants or thrombolytics, can significantly improve outcomes and reduce the risk of complications such as heart failure or recurrent embolism.

Through lifestyle changes, appropriate prevention measures, and timely treatment, the prognosis for many individuals with PE can be significantly improved.

The key to surviving and thriving after a pulmonary embolism is awareness of the risk factors, quick action when symptoms appear, and effective management of the condition under medical guidance.

References:

Disclaimer:

This article is intended for informational and educational purposes only. We are not medical professionals, and this content does not replace professional medical advice, diagnosis, or treatment.

The goal is to provide accurate, evidence-based information to raise awareness of pulmonary embolism (PE) and related conditions. If you are experiencing persistent, severe, or concerning symptoms, you should seek guidance from a qualified healthcare provider.